By elucidating the complex interplay between TSPAN32 and immune cell biology, this study opens new avenues for therapeutic interventions targeting TSPAN32 in immune-related diseases, cancer immunotherapy, and hematological disorders. Here, TSPAN32 is linked to hematologic disorder.